Variable | CF (n = 30) | InF (n = 9) | NoF (n = 56) | P(CF vs. InF) | P(CF vs. NoF) |
---|---|---|---|---|---|
Age (mean ± SD) | 73.67 ± 13.64 | 75.78 ± 11.45 | 72.71 ± 12.02 | 0.676 | 0.739 |
Male (%) | 40 | 66.7 | 57.1 | 0.159 | 0.13 |
Hypertension (%) | 75.9 | 88.9 | 76.8 | 0.402 | 0.924 |
Beta blockers (%) | 21.4 | 33.3 | 30.4 | 0.657 | 0.387 |
Ca channel blockers (%) | 32.1 | 33.3 | 28.6 | 1 | 0.736 |
ACEi/ARB (%) | 50 | 33.3 | 39.3 | 0.462 | 0.35 |
Diuretics (%) | 21.4 | 11.1 | 8.9 | 0.656 | 0.168 |
Smoking (%) | 20 | 0 | 17.3 | 0.56 | 0.762 |
Diabetes Mellitus (%) | 29.6 | 22.2 | 33.9 | 1 | 0.153 |
Previous CVA (%) | 25 | 11.1 | 14.3 | 0.649 | 0.227 |
Previous ICH (%) | 7.1 | 11.1 | 3.6 | 1 | 0.598 |
Antiplatelet treatment (%) | 57.1 | 33.3 | 50 | 0.269 | 0.537 |
Anti-Coagulation (%) | 10.3 | 22.2 | 14.3 | 0.574 | 0.742 |
INR (mean ± SD) | 1.2 ± 0.583 | 1.48 ± 0.837 | 1.41 ± 1.255 | 0.27 | 0.404 |
PTT (mean ± SD) | 26.79 ± 5.12 | 30.55 ± 9.91 | 29.33 ± 8.09 | 0.302 | 0.138 |
Platelets count (mean ± SD) | 232.3 ± 72.58 | 177.5 ± 31.04 | 231.57 ± 93.6 | 0.003 | 0.971 |